NMM
VRNA

Naples Money Management’s Verona Pharma VRNA Stock Holding History

Naples Money Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$1.55K – 444
2024
Q2 		$1.55K Buy
+100
New +$1.46K ﹤0.01% 335

Other funds holding VRNA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Naples Money Management's VRNA Position: Q3 2024 in Review

Naples Money Management sold out of Verona Pharma (VRNA) in Q3 2024, closing a stake of 100 shares — an estimated $1.55K sold.

Naples Money Management first reported a position in VRNA in Q2 2024 and held it in 1 quarter. The position peaked at $1.55K in Q2 2024. 150 funds tracked by Wall St. Rank hold VRNA as of Q3 2024.

  • Naples Money Management reported no remaining Verona Pharma position as of Q3 2024 after selling out during the quarter.
  • Naples Money Management sold 100 Verona Pharma shares in Q3 2024, an estimated $1.55K.
  • Naples Money Management first reported a position in Verona Pharma in Q2 2024 and held it in 1 quarter.
  • Naples Money Management's Verona Pharma position peaked at $1.55K in Q2 2024.
  • 150 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.